Benzinga's Top #PreMarket Losers

By: via Benzinga
ImmunoGen, Inc. (NASDAQ: IMGN) shares dropped 45.30% to $5.94 after the company reported that Roche has provided an update on the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.